Product Reports Resources Pricing Login Book a demo

Blackrock Neurotech

Biotech & Life Sciences · Salt Lake City, United States · Founded 2008

Manufactures a wide range of scientific equipment to record bio-potentials from the central and peripheral nervous system in both chronic and acute applications MoreLess

Blackrock Neurotech is a biotechnology company that develops brain-computer interface (BCI) technology. The company's mission is to provide tools that help people with paralysis and other neurological disorders to communicate and control their environment.

Blackrock Neurotech's main product is the Utah Array, a microelectrode array that is implanted in the brain to record neural signals. The company also provides software and hardware that allow users to decode these signals and use them to control external devices, such as computers and prosthetic limbs. The company's business model is based on selling its BCI systems to research institutions and medical device companies. Blackrock Neurotech also generates revenue from providing engineering and consulting services to its clients.

Keywords: brain-computer interface, neurotechnology, medical devices, neural engineering, neuroprosthetics, clinical neuroscience, restorative neurology, neural interfaces, electrophysiology, biomedical engineering

Company overview

Blackrock Neurotech company information

The essential company record, classifications and operating signals in one place.

Status
Acquired
Founded
2008
Headquarters
Salt Lake City, United States
Employees
191
Open positions
None listed
Dealroom signal
80.4
Investment activity
2 companies · latest Apr 2022
Capital deployed
$3.3M
Preferred round
SEED
client focusb2bsub industryBioTechnologysub industryMedical Devicesbusiness modelManufacturingsectorRehabilitationindustryHealthsectorBiotechnologysectorSpinoutsectorBiotech and PharmasectorBrain Computer InterfacessectorDT and LSsectorscience-based

Valuation & funding

Blackrock Neurotech funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GROWTH EQUITY VCEquity / VC May 2024 $12M Undisclosed
ACQUISITIONExit Apr 2024 $200M Tether
LATE VCEquity / VC Jul 2023 $0 Presight Capital
LATE VCEquity / VC May 2021 $10M $40M Peter Thiel · Sorenson Impact Foundation · re.Mind Capital · 2050 Capital
SPINOUTOther financing Jan 2008 $0 University of Utah
Showing 5 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 191
2025 160
2024 128
2023 134
2022 161
2021 89
2020 58
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Blackrock Neurotech website traffic

Latest recorded traffic for Blackrock Neurotech is 21K monthly website visits, up 31.3% over the last three months. Blackrock Neurotech's team grew 19.4% over the past year.

Latest monthly visits21K 3-month web change+31.3% 1-year team growth+19.4%
Monthly website visits64 observations · Oct 2020–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Blackrock Neurotech compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Blackrock Neurotech's talent

Book a demo to see the people
Team profiled 14 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

11 investors on Blackrock Neurotech's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series B+ 6 investors entered at this stage
Peter Thiel
Sorenson Impact Foundation
re.Mind Capital
2050 Capital
Tim Sievers
Presight Capital
Other known 5 additional known investors
Tether
University of Utah
Ajay Juneja
KLIWLA Family Office
What If Ventures

Global footprint

Where Blackrock Neurotech has talent and traffic

Workforce by country
9 countries with
team presence
🇺🇸 United States92.7%
🇫🇷 France1.6%
🇩🇪 Germany0.8%
🇧🇷 Brazil0.8%
🇮🇳 India0.8%
Top 5 of 9 shown

In the news

Latest news about Blackrock Neurotech

Recent press, funding announcements, and product moves mentioning Blackrock Neurotech — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Blackrock Neurotech

An AI-synthesized read of the highest-engagement posts about Blackrock Neurotech on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Blackrock Neurotech’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.